KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Revenue (2016 - 2025)

Historic Revenue for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $19.3 billion.

  • Eli Lilly's Revenue rose 4255.42% to $19.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $65.2 billion, marking a year-over-year increase of 4470.39%. This contributed to the annual value of $65.2 billion for FY2025, which is 4470.39% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Revenue is $19.3 billion, which was up 4255.42% from $17.6 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Revenue registered a high of $19.3 billion during Q4 2025, and its lowest value of $6.5 billion during Q2 2022.
  • In the last 5 years, Eli Lilly's Revenue had a median value of $8.5 billion in 2023 and averaged $10.1 billion.
  • Its Revenue has fluctuated over the past 5 years, first crashed by 1088.35% in 2023, then skyrocketed by 5386.53% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Revenue stood at $8.0 billion in 2021, then dropped by 8.73% to $7.3 billion in 2022, then grew by 28.1% to $9.4 billion in 2023, then skyrocketed by 44.69% to $13.5 billion in 2024, then skyrocketed by 42.55% to $19.3 billion in 2025.
  • Its Revenue stands at $19.3 billion for Q4 2025, versus $17.6 billion for Q3 2025 and $15.6 billion for Q2 2025.